BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poullis AP, Shetty AK, Risley PD, Collinson PO, Mendall MA. Effect of the CD14 promoter polymorphism on liver function tests and its association with alcohol and obesity. Eur J Gastroenterol Hepatol 2003;15:1317-22. [PMID: 14624155 DOI: 10.1097/00042737-200312000-00010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, Vidal C. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol Clin Exp Res. 2005;29:1206-1213. [PMID: 16046876 DOI: 10.1097/01.alc.0000171977.25531.7a] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
2 Meiler C, Mühlbauer M, Johann M, Hartmann A, Schnabl B, Wodarz N, Schmitz G, Schölmerich J, Hellerbrand C. Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World J Gastroenterol 2005; 11(38): 6031-6037 [PMID: 16273620 DOI: 10.3748/wjg.v11.i38.6031] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
3 Zhang L, Pu K, Chai Z, Dixon JB. Family history of coronary heart disease is associated with a higher incidence of nonalcoholic fatty liver disease: Central obesity the likely link. Obesity Research & Clinical Practice 2007;1:125-31. [DOI: 10.1016/j.orcp.2007.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, Bernardi M. Review article: alcoholic liver disease--pathophysiological aspects and risk factors. Aliment Pharmacol Ther. 2006;24:1151-1161. [PMID: 17014574 DOI: 10.1111/j.1365-2036.2006.03110.x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 109] [Article Influence: 9.3] [Reference Citation Analysis]
5 Shin HD, Park KS, Park BL, Cheong HS, Cho YM, Lee HK, Lee JY, Lee JK, Kim HT, Han BG, Kim JW, Koh I, Kim YJ, Oh B, Kimm K, Park C. Common promoter polymorphism in monocyte differentiation antigen CD14 is associated with serum triglyceride levels and body mass index in non-diabetic individuals. Diabet Med 2006;23:72-6. [PMID: 16409569 DOI: 10.1111/j.1464-5491.2005.01732.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]